P roduct recalls represent a significant and constant concern in the management of medication safety, involving the temporary or permanent withdrawal of drugs, biologics, foods, and medical devices. In the first 11 months of 2010, the US Food and Drug Administration (FDA) listed approximately 350 notifications of significant product recalls for drugs, devices, and food/food supplements. Of these, approximately 15% represented recalls related to drugs, dietary supplements, and medical devices. 1 In addition, 2010 brought the market withdrawal of propoxyphene, sibutramine, and gemtuzumab. 2 Drug recalls, the removal of a medication from the market, may be initiated by a pharmaceutical manufacturer or via FDA request. Removal may range from a limited recall involving specific lot numbers of the product to a permanent full market withdrawal of the drug. In all cases, the recall of a drug or product is issued when there is an unreasonable risk of harm. Typically, recalls are classified according to the potential health risk and consequences associated with use or exposure to the product. 3 Class I recalls pose the most serious risk or potential for death; Class II recalls may be associated with temporary or medically reversible health outcomes or where the risk of serious outcomes is remote; and Class III recalls are not likely to cause adverse health outcomes.
Hospital pharmacists are responsible for global drug control in a variety of settings including, but not limited to, inpatient nursing units, drug distribution centers, automated systems, outpatient clinics/pharmacies, and specialty procedure areas. Although much attention is focused on the safe practices regarding procurement and distribution of medications, pharmacists are also very involved in the management of drug recalls.
Keeping current with product recalls and implementing timely actions remain a challenge for pharmacists. Currently, there is no standard notification of all recalls or market withdrawals, although much of this information may be gleaned from a variety of sources, including drug wholesalers, vendors specializing in safety data, direct manufacturer correspondence, and/ or announcements from the FDA. 4 The growing number and diversity of recalled products, the varied urgency related to each recall, and the unpredictable nature of these events require a coordinated effort to develop a comprehensive and effective recall management program. Standard practices recommend that hospital pharmacies develop and maintain a written procedure that details the process and handling of a drug product during a recall or market withdrawal. 5 Elements essential to an effective recall management program include the immediate removal of the drug product from patient care areas and inventory sites and quarantine of the recalled product until appropriate disposal or removal. Maintenance of a recall log that records all actions is also considered standard practice. In certain situations where the risk of harm is significant, patients receiving the drug should be notified. In the case of a full market withdrawal of a specific drug, it may be feasible via automated means to determine which patients received the medication over a defined time period. However, despite advances in technology and the increased application of these processes in the health care arena, it is still difficult in many health care settings to tie a specific lot number of a drug to a specific set of patients receiving that agent. Some exceptions to this rule may be the administration of certain biologics or vaccines, where it is common practice to note the lot number on a drug order or patient profile. But even in cases where documentation is available in the patient record or on the prescription, sometimes it is difficult to readily retrieve the information. The use of bar-coding medications has been proposed as one method to assist in the retrieval of information in the case of a drug recall, but relatively few hospitals across the nation are equipped with this advantage.
The effective management of drug recalls to optimize patient care is a constant concern. In the light of increasing number of product recalls, the allocation of *Director, Drug Information Center, Kansas University Medical Center, Kansas City, Kansas.
Hospital Pharmacy resources to develop and efficiently manage such programs requires a crucial balance. Hosptial Pharmacy is very interested in your experiences in this area.
